Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001323113-18-000003
Filing Date
2018-01-09
Accepted
2018-01-09 17:30:13
Documents
2
Period of Report
2018-01-03

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 3  
1 PRIMARY DOCUMENT edgardoc.xml 3 1543
2 EDGAR SUPPORTING DOCUMENT poaswisher.txt EX-24 3683
  Complete submission text file 0001323113-18-000003.txt   6773
Mailing Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4
Business Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4 353-1-634-7800
Jazz Pharmaceuticals plc (Issuer) CIK: 0001232524 (see all company filings)

EIN.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SUNESIS PHARMACEUTICALS, INC. 395 OYSTER POINT BLVD., SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address
Swisher Daniel N JR (Reporting) CIK: 0001323113 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33500 | Film No.: 18519854